205 related articles for article (PubMed ID: 30302775)
21. Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs.
Gutiérrez L; Velasco ZH; Vázquez C; Vargas D; Sumano H
Acta Vet Scand; 2012 Jun; 54(1):35. PubMed ID: 22682068
[TBL] [Abstract][Full Text] [Related]
22. Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs.
Batzias GC; Delis GA; Athanasiou LV
Vet J; 2005 Nov; 170(3):339-45. PubMed ID: 16266847
[TBL] [Abstract][Full Text] [Related]
23. Danofloxacin pharmacokinetics and tissue residues in Bilgorajska geese.
Sartini I; Łebkowska-Wieruszewska B; Lisowski A; Poapolathep A; Giorgi M
Res Vet Sci; 2021 May; 136():11-17. PubMed ID: 33556838
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of orbifloxacin in crucian carp (Carassius auratus) after intravenous and intramuscular administration.
Yang F; Yang F; Wang G; Shi W; Kong T; Yang P; Bai D; Zhou B
J Vet Pharmacol Ther; 2018 Aug; 41(4):599-604. PubMed ID: 29465160
[TBL] [Abstract][Full Text] [Related]
25. Effect of food on the pharmacokinetics of oral cefuroxime axetil in dogs.
Albarellos GA; Passini SM; Lupi MP; Aramayona S; Lorenzini PM; Montoya L; Landoni MF
J Vet Pharmacol Ther; 2020 May; 43(3):297-302. PubMed ID: 32157713
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of norfloxacin after intravenous, intramuscular and subcutaneous administration to rabbits.
Marín P; García-Martínez F; Hernándis V; Escudero E
J Vet Pharmacol Ther; 2018 Feb; 41(1):137-141. PubMed ID: 28603857
[TBL] [Abstract][Full Text] [Related]
27. [Study of pharmacokinetics/pharmacodynamics of levofloxacin].
Zhang J; Yu JC; Shi YG; Zhou L; Ye XY; Zhu DM; Zhang YY
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1926-32. PubMed ID: 16255991
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and pharmacodynamics of levofloxacin injection in healthy Chinese volunteers and dosing regimen optimization.
Cao G; Zhang J; Wu X; Yu J; Chen Y; Ye X; Zhu D; Zhang Y; Guo B; Shi Y
J Clin Pharm Ther; 2013 Oct; 38(5):394-400. PubMed ID: 23701411
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of marbofloxacin in dogs after oral and parenteral administration.
Schneider M; Thomas V; Boisrame B; Deleforge J
J Vet Pharmacol Ther; 1996 Feb; 19(1):56-61. PubMed ID: 8992027
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and Acid Suppressant Efficacy of Esomeprazole after Intravenous, Oral, and Subcutaneous Administration to Healthy Beagle Dogs.
Hwang JH; Jeong JW; Song GH; Koo TS; Seo KW
J Vet Intern Med; 2017 May; 31(3):743-750. PubMed ID: 28407418
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and bioavailability of tildipirosin following intravenous and subcutaneous administration in sheep.
Abu-Basha EA; Bani Ismail Z; Abu Alhaijaa H; Hamzeh E; Idkaidek NM
J Vet Pharmacol Ther; 2021 Jan; 44(1):79-85. PubMed ID: 32748450
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of clindamycin HCl administered intravenously, intramuscularly and subcutaneously to dogs.
Lavy E; Ziv G; Shem-Tov M; Glickman A; Dey A
J Vet Pharmacol Ther; 1999 Aug; 22(4):261-5. PubMed ID: 10499238
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of an intravenous and oral dose of enrofloxacin in white rhinoceros (Ceratotherium simum).
Leiberich M; Krebber R; Hewetson M; Marais J; Naidoo V
J Vet Pharmacol Ther; 2019 May; 42(3):346-354. PubMed ID: 30656701
[TBL] [Abstract][Full Text] [Related]
34. Population pharmacokinetics of oral levofloxacin in healthy volunteers and dosing optimization for multidrug-resistant tuberculosis therapy.
Boonpeng A; Jaruratanasirikul S; Wattanavijitkul T; Nawakitrangsan M; Samaeng M
Biopharm Drug Dispos; 2021 Jul; 42(7):329-337. PubMed ID: 34117648
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of ceftiofur sodium in cats following a single intravenous and subcutaneous injection.
Zhang M; Yang F; Yu HJ; Kang TJ; Ding YH; Yu ML; Wang QK; Zhu YX; Yang F
J Vet Pharmacol Ther; 2019 Nov; 42(6):602-608. PubMed ID: 31529627
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic profiles of levofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits (
Sitovs A; Voiko L; Kustovs D; Kovalcuka L; Bandere D; Purvina S; Giorgi M
J Vet Sci; 2020 Mar; 21(2):e32. PubMed ID: 32233138
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of gamithromycin after intravenous and subcutaneous administration in pigs.
Wyns H; Meyer E; Plessers E; Watteyn A; De Baere S; De Backer P; Croubels S
Res Vet Sci; 2014 Feb; 96(1):160-3. PubMed ID: 24331716
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of marbofloxacin in rabbit after intravenous, intramuscular, and subcutaneous administration.
Marín P; Alamo LF; Escudero E; Fernández-Varón E; Hernandis V; Cárceles CM
Res Vet Sci; 2013 Jun; 94(3):698-700. PubMed ID: 23434066
[TBL] [Abstract][Full Text] [Related]
39. Resistant cutoff values and optimal scheme establishments for florfenicol against Escherichia coli with PK-PD modeling analysis in pigs.
Lei Z; Liu Q; Khaliq H; Cao J; He Q
J Vet Pharmacol Ther; 2019 May; 42(3):324-335. PubMed ID: 30801741
[TBL] [Abstract][Full Text] [Related]
40. The clinical pharmacokinetics of levofloxacin.
Fish DN; Chow AT
Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
